comparemela.com

Latest Breaking News On - 500 rare disease drugs innovation and development - Page 1 : comparemela.com

DOLOXE Inc announces Clinical Trial Planner tool

Santa Clara (California) [US], September 14 (ANI/PRNewswire): Advanced software tools continue to play a major role in 4,500+ rare disease drugs innovation and development, helping overcome challenges such as limited availability of patients and high-risk costs. To ensure successful remedies, patient screening must get simpler, cost-efficient, and faster to recruit. DOLOXE Inc's Clinical Trial Planner tool has made all these possible. It incorporates unique drop-and-drag data field searches and accurate data insights, which can reduce trial protocol design and patient recruitment time by more than 30 per cent. Highlights of the tool 1. Built based on 40,000-plus completed trails, 18,000 ongoing trials and 5,000-plus planned trials enrolment and study period analysis. New protocol design and enrolment planning can be automated based on the above data sets. 2. The software application comes with drag-and-drop fields aligned with data analytics platforms such as Tableau and Power BI t

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.